BONITA CLAYTON: Open Payments
NPI 1023172590 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 29 payments from 6 companies in 2025. Trend: 2023 $213 · 2024 $283 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $510 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| AppliedVR Inc | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
Products named: UBRELVY, AIRSUPRA, QULIPTA, VRAYLAR, RelieVRx, XIFAXAN, UNITHROID.
Industry payments across PA — which companies pay providers there.
